Anti-ZNFX1 antibody [EPR12330] - BSA and Azide free
- RabMAb
- Recombinant
- 각 태그의 뜻
Be the first to review this product! 리뷰 제출
|
(0 출판물)
Rabbit Recombinant Monoclonal ZNFX1 antibody. Carrier free. Suitable for WB and reacts with Human samples.
대체 명칭 보기
KIAA1404, ZNFX1, NFX1-type zinc finger-containing protein 1
- WB
Supplier Data
Western blot - Anti-ZNFX1 antibody [EPR12330] - BSA and Azide free (AB250095)
This data was developed using ab179452, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-ZNFX1 antibody [EPR12330] (<a href='/ko/products/primary-antibodies/znfx1-antibody-epr12330-ab179452'>ab179452</a>) at 1/1000 dilution
Lane 1:
MCF7 cell lysate at 10 µg
Lane 2:
K562 cell lysate at 10 µg
Lane 3:
HeLa cell lysate at 10 µg
Predicted band size: 220 kDa
false
- WB
Unknown
Western blot - Anti-ZNFX1 antibody [EPR12330] - BSA and Azide free (AB250095)
This data was developed using ab179452, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-ZNFX1 antibody [EPR12330] (<a href='/ko/products/primary-antibodies/znfx1-antibody-epr12330-ab179452'>ab179452</a>) at 1/1000 dilution
All lanes:
K-562 (Human chronic myelogenous leukemia lymphoblast) whole cell lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 220 kDa
Observed band size: 220 kDa
false
관련 conjugated 항체와 다양한 조성의 항체 (1)
-
Anti-ZNFX1 antibody [EPR12330]
Reactivity 정보
제품 세부 정보
ab250095 is the carrier-free version of ab179452.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ZNFX1 influences immune function and viral defense mechanisms. Acting within ribonucleoprotein complexes it participates in the sensing of double-stranded RNA an indicator of viral infection. ZNFX1 helps modulate type I interferon responses a critical aspect of host defense. In these processes it interacts with other proteins necessary for the immune system contributing to maintaining cellular immune surveillance and controlling viral replication.
Pathways
The actions of ZNFX1 integrate into pathways related to RNA processing and immune responses. Specifically ZNFX1 is involved in the RIG-I-like receptor (RLR) pathway which is important for antiviral responses. In this pathway ZNFX1 interacts with proteins like RIG-I and MAVS to facilitate the proper functioning of antiviral signaling cascades. This pathway's coordination leads to the activation of transcription factors that promote the expression of type I interferons and other cytokines essential for antiviral immunity.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com